文献速递产科母胎医学

母体血清中胎盘与妊娠相关蛋白的遗传关联识别妊娠期高血压的生物标志物

Genetic associations with placental and pregnancy proteins in maternal serum identify biomarkers for hypertension in pregnancy.
PubMed 文献 · Am J Obstet Gynecol · 2025-11-01

该研究采用嵌套病例对照设计,纳入2010至2013年美国8个临床中心的2352名初产妇,检测孕早、中期9种血清蛋白并进行全基因组关联分析和孟德尔随机化分析。发现ADAM12、VEGF和sFlt-1浓度与遗传位点显著关联,孕早期ADAM12浓度与妊娠期高血压相关(OR=0.78,P<.001),且子痫前期和妊娠期高血压与2至7年后高血压风险升高相关。

要点

  • 孕早期ADAM12浓度与妊娠期高血压相关(OR=0.78,P<.001)。
  • 子痫前期(OR=1.75,P=8.3×10-3)和妊娠期高血压(OR=1.84,P=.005)与2至7年后高血压风险升高相关。
  • 妊娠区带蛋白位点与ADAM12浓度显著关联(rs6487735,P=3.03×10-22)。

核心结论

  • 研究发现胎盘蛋白ADAM12、VEGF和sFlt-1与遗传位点显著关联,孟德尔随机化分析表明血清蛋白浓度尤其ADAM12与妊娠期高血压相关,可能为未来预防和治疗研究提供信息。

研究设计与样本

  • 采用嵌套病例对照设计,纳入2010至2013年美国8个临床中心参加Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be研究的初产妇,采集孕早期和孕中期血清样本,检测9种蛋白,进行全基因组关联分析(以蛋白为结局)和孟德尔随机化分析(以蛋白为暴露)。

主要发现

  • 共分析2352名参与者。
  • 妊娠区带蛋白位点与ADAM12浓度显著关联(rs6487735,P=3.03×10-22)。
  • 血管内皮生长因子A位点与VEGF浓度(rs6921438,P=7.94×10-30)和sFlt-1浓度(rs4349809,P=2.89×10-12)均显著关联。
  • 孟德尔随机化分析显示孕早期ADAM12浓度与妊娠期高血压相关(OR=0.78,P<.001)。
  • 索引妊娠期子痫前期(OR=1.75,P=8.3×10-3)和妊娠期高血压(OR=1.84,P=.005)与2至7年后高血压风险升高相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preeclampsia is a complex syndrome that accounts for considerable maternal and perinatal morbidity and mortality. Despite its prevalence, no effective disease-modifying therapies are available. Maternal serum placenta-derived proteins have been in longstanding use as markers of risk for aneuploidy and placental dysfunction, but whether they have a causal contribution to preeclampsia is unknown. OBJECTIVE: We aimed to investigate the genetic regulation of serum placental and pregnancy proteins in early pregnancy and their relationships with preeclampsia and gestational hypertension. STUDY DESIGN: This study used a nested case-control design with nulliparous women enrolled in the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be study from 8 clinical sites across the United States between 2010 and 2013. The first-trimester and second-trimester serum samples were collected, and 9 proteins were measured, including vascular endothelial growth factor, placental growth factor, endoglin, soluble fms-like tyrosine kinase-1, a disintegrin and metalloproteinase domain-containing protein 12, pregnancy-associated plasma protein A, free beta-human chorionic gonadotropin, inhibin A, and alpha-fetoprotein. This study used genome-wide association studies to discern genetic influences on these protein concentrations, treating proteins as outcomes. Furthermore, Mendelian randomization was used to evaluate the effects of these proteins on preeclampsia and gestational hypertension, and their further relationship with long-term hypertension, treating proteins as exposures. RESULTS: A total of 2352 participants were analyzed. We discovered significant associations between the pregnancy zone protein locus and concentrations of a disintegrin and metalloproteinase domain-containing protein 12 (rs6487735, P=3.03×10-22) and between the vascular endothelial growth factor A locus and concentrations of both vascular endothelial growth factor (rs6921438, P=7.94×10-30) and soluble fms-like tyrosine kinase-1 (rs4349809, P=2.89×10-12). Our Mendelian randomization analyses revealed an association between first-trimester a disintegrin and metalloproteinase domain-containing protein 12 concentrations and gestational hypertension (odds ratio=0.78, P<.001). We also found that preeclampsia (odds ratio=1.75, P=8.3×10-3) and gestational hypertension (odds ratio=1.84, P=.005) during the index pregnancy were associated with an increased risk of hypertension 2 to 7 years later. CONCLUSION: Our study discovered significant genetic associations with placental proteins a disintegrin and metalloproteinase domain-containing protein 12, vascular endothelial growth factor, and soluble fms-like tyrosine kinase-1, offering insights into their regulation during pregnancy. Mendelian randomization analyses demonstrated the associations between the serum concentrations of proteins, particularly a disintegrin and metalloproteinase domain-containing protein 12, and gestational hypertension, potentially informing future prevention and treatment investigations.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Yan Q, Zhang Y, Blue NR, et al. Genetic associations with placental and pregnancy proteins in maternal serum identify biomarkers for hypertension in pregnancy. Am J Obstet Gynecol. 2025. PMID: 41183724. doi:10.1016/j.ajog.2025.10.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。